The format for the submission of information on medicines is published
July 25, 2011The European Medicines Agency has recently published the format in which pharmaceutical companies will need to submit information regarding authorised …
FDA sets aside $700,000 for manufacturing research
July 25, 2011Manufacturing and Production FDA, pharma manufacturing news
The FDA has set aside $700,000 to help fund research that “improves reliability of pharmaceutical product manufacturing and quality across …
Pharma manufacturing news in brief
July 25, 2011Manufacturing and Production pharma manufacturing news
Another recall for generics manufacturer American Regent, facility updates from Sanofi, Beximco, Lanxess and Anomatic, plus a new general manager …
BMS makes $325m biotech acquisition
July 25, 2011Research and Development, Sales and Marketing BMS, biotech, research and development news
Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
Roche cancer drug Tarceva set for first-line licence
July 25, 2011Sales and Marketing Cancer, Roche, Tarceva
Roche’s cancer drug Tarceva is on course to win a first-line indication in Europe for the first time after regulatory …
Afinitor poised to realise blockbuster ambitions?
July 25, 2011Sales and Marketing Afinitor, Cancer, Novartis
Novartis’ Afinitor may be set to make good on its blockbuster promise after receiving European backing for its second licence …
Sanofi bags GSK’s Anne Whitaker for US role
July 25, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Sanofi has appointed Anne Whitaker president of its US pharmaceutical operations. She joins the company from GlaxoSmithKline, where she served …
Digital Pharma: Pfizer’s Facebook page hacked
July 22, 2011Medical Communications Digital Pharma blog, Facebook, Pfizer
Pfizer has regained control of its corporate Facebook page after hackers temporarily defaced it earlier this week. A UK group …
Lilly posts strong quarterly results, faces challenges ahead
July 22, 2011Sales and Marketing lilly, patent expiry
Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …
Teva closes one Canadian plant, expands two more
July 22, 2011Manufacturing and Production Canada, Teva
Teva Pharmaceutical has decided to shut down its recently-acquired manufacturing Canadian facility in Montreal, Quebec, having failed to find a …
Merck and Roche extend Victrelis co-promotion deal to Europe
July 22, 2011Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C
Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
European reprieve for Takeda’s Actos
July 22, 2011Sales and Marketing Actos, diabetes
Takeda’s Actos is likely to remain on the market in Europe but regulators want the diabetes drug to carry stronger …
Digital Pharma: Mobile app regulation
July 21, 2011Medical Communications, Sales and Marketing Digital Phama blog, app, ipad, iphone, mobile
The FDA has proposed new rules for smartphone apps, but says the guidelines will only apply to a small number …
Service Insight: Logical logistics
July 21, 2011Manufacturing and Production Service Insight, manufacturing and production
SERVICE INSIGHTThere is no mistaking that we have been faced with turbulent times over the last year or so and …
FDA approves AstraZeneca’s Brilinta after delay
July 21, 2011Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet
The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year. …
MSI appoints new managing director
July 21, 2011Sales and Marketing appointment, sales and marketing
UK-based pharmaceutical consultancy the MSI Consultancy has appointed Jon Bircher as managing director. He joined MSI in January 2006 from …
Lilly presents data on failed Alzheimer’s candidate
July 21, 2011Research and Development Alzheimer's disease, lilly, research and development news, semagacestat
Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …
AZ adds new heart warning to Seroquel
July 21, 2011Sales and Marketing Seroquel, antipsychotic
AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
Merck signs major deal with China’s Simcere
July 21, 2011Sales and Marketing Merck, Simcere, emerging markets
Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …
Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products
July 20, 2011Manufacturing and Production
Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
